This raises peri-procedural concerns regarding anesthesia/pulmonary aspiration risks, poor visibility, and the need for repeat procedures, all of which contribute to significant time, cost, and resource utilization burden
PMC 2633544
New data suggests GLP-1 users were also less likely to see cancer spread to other organs, but this work is yet to be verified by other researchers
MS accurately determines molecular weights and modification sites, essential for assessing peptide function and therapeutic potential
Nearly two-fifths (37 per cent) of Canadian employers cover glucagon-like peptide-1 therapies for both diabetes and weight loss, up from 31 per cent in 2025 and just 17 per cent in 2024, according to a new survey by the International Foundation of Employee Benefit Plans
Yes, they target visceral fat effectively